Search

everythinglearnresearchcommunity

for

Search:↓

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Analyzing follicular fluid can help predict and improve outcomes for women with PCOS undergoing fertility treatments.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Consider rare forms of CAH for accurate diagnosis and treatment.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Personalized acne treatments and new therapies show promise for better results.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

PCOS is the most common cause of hirsutism, and personalized treatment is important.

PCOS is linked to chronic low-grade inflammation, but the role of certain infections is unclear.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Sex hormones affect liver fat and metabolic health differently in men and women.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.